γδ T 细胞调节小细胞肺癌中的抗肿瘤免疫
γδ T cells modulate anti-tumor immunity in small cell lung cancer.
我们的发现表明,活化的γδ T细胞可能是SCLC治疗的有价值靶点。
英文原题:Development and validation of an interpretable prediction model using spatial patterns of tumor-infiltrating lymphocytes in H&E-stained whole-slide images for immune subtyping of lung adenocarcinoma.
本研究基于 H&E 染色切片中 TIL 的空间分布,建立了 LUAD 的可解释免疫亚型预测模型。
目的:通过量化苏木精-伊红(H&E)全切片图像中TIL(肿瘤浸润淋巴细胞)的空间分布模式,开发一种可解释的肺腺癌免疫亚型预测模型,为评估肿瘤免疫微环境提供计算工具。 方法:在TCGA肺腺癌队列中采用ssGSEA量化免疫基因集活性,继而进行层次聚类和t-SNE可视化,将患者划分为高免疫和低免疫亚组。采用CIBERSORT评估免疫细胞浸润,并使用maftools分析肿瘤突变负荷和体细胞突变谱。通过GO和KEGG数据库开展差异表达及功能富集分析。在病理图像分析中,采用基于本研究数据优化的自动注释模型处理全切片图像。通过量化TIL(肿瘤浸润淋巴细胞)的空间分布特征建立免疫亚型预测标准,并在内部和外部队列中验证模型预测性能。 结果:转录组分析将503例肺腺癌(LUAD)患者分为高免疫和低免疫亚组。高免疫组CD8+ T细胞和M1巨噬细胞浸润较高、肿瘤突变负荷较高,且T细胞活化通路富集;低免疫组则以静息免疫细胞为主。自动注释模型在组织轮廓分割和肿瘤实质分割中的Dice评分分别为95.09%和91.53%;识别TIL的F1评分为79.51%,mAP@0.5为82.13%。以0.2为高注意力阈值进行TIL空间分布定量分析,并采用0.05分类截点建立免疫亚型模型;该模型在内部验证队列中的免疫亚型分类AUC为0.839。在外部验证队列中,AUC为0.927;免疫组化分析证实,模型预测为高免疫的样本中CD3+、CD8+、CD20+和CD68+细胞密度显著更高。 结论:本研究建立了一种基于H&E染色切片中TIL空间分布、用于LUAD的可解释免疫亚型预测模型。该模型采用模块化设计,整合深度学习注释和统计分类,在整个分析流程保持透明且可验证的同时,将形态学表型与分子免疫亚型相联系。这一成本效益较高且可扩展的工具有望用于评估肿瘤免疫状态并指导免疫治疗决策。
OBJECTIVE: To develop an interpretable prediction model for lung adenocarcinoma immune subtyping by quantifying spatial distribution patterns of tumor-infiltrating lymphocytes in H&E whole-slide images, providing a computational tool for tumor immune microenvironment evaluation. METHODS: Immune subtyping was performed on the TCGA lung adenocarcinoma cohort using ssGSEA to quantify immune gene set activity, followed by hierarchical clustering and t-SNE visualization to stratify patients into high- and low-immunity subgroups. Immune cell infiltration was assessed using CIBERSORT, while tumor mutation burden and somatic mutation profiles were analyzed with maftools. Differential expression and functional enrichment analyses were conducted using GO and KEGG databases. In pathological image analysis, an automated annotation model optimized with study-specific data was employed to process whole-slide images. Immune subtype prediction criteria were established by quantifying spatial distribution features of tumor-infiltrating lymphocytes. The model's predictive performance was validated in both internal and external cohorts. RESULTS: Transcriptomic analysis stratified 503 LUAD patients into high- and low-immunity subgroups. The high-immunity group exhibited elevated infiltration of CD8 + T cells and M1 macrophages, higher tumor mutation burden, and enriched T cell activation pathways. The low-immunity group showed predominant resting immune cells. The automated annotation model, achieved a 95.09% Dice score for tissue contour segmentation, 91.53% for tumor parenchyma segmentation, and a 79.51% F1-score with an mAP@0.5 of 82.13% for TIL identification. Quantitative TIL spatial distribution analysis with a 0.2 high-attention threshold enabled development of an immune subtyping model using a 0.05 classification cutoff, which achieved an AUC of 0.839 for immune subtype classification in the internal validation cohort. In the external validation cohort, the model achieved an AUC of 0.927, and immunohistochemical analysis confirmed significantly higher densities of CD3 + , CD8 + , CD20 + , and CD68 + cells in predicted high-immunity samples. CONCLUSION: This study establishes an interpretable immune subtype prediction model for LUAD based on TIL spatial distribution in H&E-stained sections. Through a modular design that integrates deep learning-based annotation with statistical classification, the model links morphological phenotypes to molecular immune subtypes while maintaining transparency and verifiability throughout the analytical workflow. This cost-effective and scalable tool offers potential value for assessing tumor immune status and guiding immunotherapy decision-making.
MEMBER ACCOUNT
登录成功会直接打开下一页。